Department of Pathology, College of Medicine and Health Sciences, United Arab Emirates University, Al-Ain, United Arab Emirates.
Department of Pediatrics, College of Medicine and Health Sciences, United Arab Emirates University, Al-Ain, United Arab Emirates.
Invest Ophthalmol Vis Sci. 2014 Apr 17;55(6):3423-31. doi: 10.1167/iovs.14-13885.
Fifteen missense mutations in the frizzled family receptor 4 (FZD4) reported to cause familial exudative vitreoretinopathy (FEVR) were evaluated to establish the pathological cellular mechanism of disease and to explore novel therapeutic strategies.
The mutations were generated by site-directed mutagenesis and expressed in HeLa and COS-7 cell lines. Confocal fluorescence microscopy and N-glycosylation profiling were used to observe the subcellular localization of the mutant proteins relative to wild-type (WT). Polyubiquitination studies were used to establish the involvement of the proteasome. Culturing at reduced temperatures and incubation in the presence of chemical compounds were used to enhance mutant protein processing and exit out of the endoplasmic reticulum (ER).
Confocal fluorescence microscopy of the mutants showed three distinct subcellular localizations, namely, a plasma membrane pattern, an ER pattern, and a mixed pattern to both compartments. Confocal fluorescence microscopy and N-glycosylation profiling established the predominant ER localization of P33S, G36N, H69Y, M105T, M105V, C181R, C204R, C204Y, and G488D mutants. Coexpression of these mutants with WT FZD4 showed the inability of the mutants to trap WT FZD4. Culturing the expressing cells at reduced temperatures or in the presence of chemical agents directed at ameliorating protein misfolding resulted in partial rescue of trafficking defects observed for M105T and C204Y mutants.
Defective trafficking resulting in haploinsufficiency is a major cellular mechanism for several missense FEVR-causing FZD4 mutants. Our findings indicate that this trafficking defect might be correctable for some mutants, which may offer opportunities for the development of novel therapeutics approaches for this condition.
对报道可引起家族性渗出性玻璃体视网膜病变(FEVR)的 15 种卷曲家族受体 4(FZD4)错义突变进行评估,以确定疾病的病理细胞机制,并探索新的治疗策略。
通过定点诱变产生突变,并在 HeLa 和 COS-7 细胞系中表达。利用共聚焦荧光显微镜和 N-糖基化分析观察突变蛋白相对于野生型(WT)的亚细胞定位。利用多聚泛素化研究确定蛋白酶体的参与。在降低温度下培养和在存在化学化合物的情况下孵育,以增强突变蛋白的加工并使其离开内质网(ER)。
突变体的共聚焦荧光显微镜显示出三种不同的亚细胞定位,即质膜模式、ER 模式和两种细胞器的混合模式。共聚焦荧光显微镜和 N-糖基化分析确定了 P33S、G36N、H69Y、M105T、M105V、C181R、C204R、C204Y 和 G488D 突变体的主要 ER 定位。这些突变体与 WT FZD4 的共表达显示突变体不能捕获 WT FZD4。在降低温度下培养表达细胞或在存在改善蛋白质错误折叠的化学试剂的情况下,可部分挽救 M105T 和 C204Y 突变体观察到的运输缺陷。
导致单倍体不足的运输缺陷是几种导致 FEVR 的 FZD4 错义突变的主要细胞机制。我们的发现表明,这种运输缺陷对于一些突变体可能是可纠正的,这可能为这种疾病的新型治疗方法的开发提供机会。